TuDiabetes Live Interview Dr. Carla Greenbaum, Director of the T1D Exchange Bioban

Carla J. Greenbaum, M.D., is a Member of the Benaroya Research Institute, where she serves as the Director of the BRI Diabetes Program and the Clinical Research Center, and is on the Institutional Review Board. She received her undergraduate and medical degrees at Brown University and completed her endocrinology fellowship at the University of Washington. Dr. Greenbaum is a clinical investigator with a focus on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune mediated beta cell function. She has conducted studies evaluating beta cell function and other physiologic and immune changes that occur during the progression of the natural history of type 1 diabetes.
In addition to clinical trials, she works to facilitate translational research initiatives locally and nationally. Her considerable expertise includes clinical trial design and implementation, and evaluation of biomarkers for disease course and response to therapy. She currently serves as Vice-Chair of Type 1 Diabetes TrialNet, an NIH sponsored international consortium to conduct multiple clinical trials in type 1 diabetes and will assume the position of Chair in 2015. In addition she heads up the HUB project, designed to work collaboratively with the Chairman’s office, clinical sites and the TNCC to identify and implement sustainable and scalable processes and improvements within the TrialNet consortium and is the PI for the Northwest Clinical Site. In this role, she is responsible for protocol development and clinical issues study wide. She is also involved with clinical trials with the NIH sponsored Immune Tolerance Network and the Diabetes Vaccine Development Center in Australia, as well as Phase I/II pharmaceutical trials.
She was appointed director of the Biobank Operations Center of the T1D Exchange, a national consortium sponsored by the Helmsley Trust. This registry and repository will facilitate the use of biological samples from T1D patients by qualified investigators in industry and academia.
Dr. Greenbaum is a member of the University of Washington’s CTSA leadership group. She serves on various national and international scientific review committees focusing on clinical and translational research. Currently, Dr. Greenbaum is on the Board of Directors of the Benaroya Research Institute.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube


Rotando las inyecciones de insulina para mejorar absorcion

Hace unos años atras lei en el libro Diabetes Solution, del Dr. Bernstein (http://www.amazon.com/gp/product/0316167169?tag=dhf-20) una tecnica que me ayudo mucho hasta que empece a usar la bomba de insulina: repartir las inyecciones de insulina de forma que cada una no exceda 6-7 unidades. En el video, explico en mas detalle. Ojala les resulte util el consejo.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube


DKA Diabetic Ketoacidosis Can Kill

Diabetic Ketoacidosis (DKA) Diabetic ketoacidosis (DKA) is a life-threatening complication in patients with untreated diabetes mellitus.

Here are some resources about DKA:
-DKA Wikipedia Page:
http://en.wikipedia.org/wiki/Diabetic_ketoacidosis

-DKA Medline Plus page:
http://www.nlm.nih.gov/medlineplus/ency/article/000320.htm

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube


TuDiabetes Live interview with Gary Scheiner, CDE: April Fools’ "Fact or Fantasy?"

In this talk we’ll focus on diabetes facts and fantasies! Will inhaled insulin replace injections and pumps? Is there a working artificial pancreas system that the FDA is holding back from approval? Can a low carb diet “cure” type 2 diabetes in people who don’t take insulin?
Bring all the rumors, whispers and conjecture you can think of. We’ll discuss what’s fact and what’s fantasy!
Gary is a certified diabetes educator, insulin-pump and continuous glucose monitor user and trainer, and Masters-level exercise physiologist. He serves on the advisory boards of several diabetes device manufacturers and pharmaceutical companies; volunteers for the Juvenile Diabetes Research Foundation, Diabetes Exercise & Sports Association, American Diabetes Association, and Setebaid diabetes camps; and serves on the faculty of Children With Diabetes. Gary teaches and art and science of blood-glucose balancing to people with diabetes throughout the world from his private practice, Integrated Diabetes Services as well as through his online school of higher learning for insulin users, Type 1 University.

Join us on the homepage of TuDiabetes for a live presentation and question-and-answer session with Gary Scheiner, founder of Integrated Diabetes Services and author of Think Like a Pancreas, The Ultimate Guide to Accurate Carb Counting, and now Until there is a Cure: the Latest and Greatest in Diabetes Self-Care.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube


Blogs


Share This: